Mosaicism: Two or more genetically distinct cell lines in one individual
Uniparental disomy (UPD): Both copies from one parent
Key Terminology
Genotype: An individual's genetic makeup
Phenotype: Observable characteristics
Allele: Alternative form of a gene
Homozygous: Two identical alleles
Heterozygous: Two different alleles
Hemizygous: Single allele (e.g. X-linked in males)
▶ Mendelian Inheritance Patterns
Pattern
Key Rule
Offspring Risk
Examples
Autosomal Dominant (AD)
One mutant copy sufficient; affected in every generation; M=F
50% if one parent affected
BRCA1/2, Huntington's, Marfan, HCM
Autosomal Recessive (AR)
Two mutant copies required; parents usually unaffected carriers; increased with consanguinity
25% affected, 50% carrier, 25% normal (carrier x carrier)
SCD, beta-thal, CF, PKU, CAH
X-linked Recessive (XLR)
Males affected; carrier females usually unaffected; no male-to-male transmission
50% of sons affected; 50% daughters carriers
G6PD, Haemophilia A/B, Duchenne MD
X-linked Dominant (XLD)
One copy on X sufficient; affected males often more severe; no male-to-male transmission
50% sons & 50% daughters if mother affected
Rett syndrome, Fragile X (partial)
Mitochondrial
Maternally inherited; all children of affected mother at risk; heteroplasmy common
All children of affected mother potentially affected
MELAS, Leber's optic neuropathy
🔎 Penetrance, Expressivity & Special Concepts
Penetrance
The proportion of individuals with a pathogenic variant who show any features of the condition. Incomplete penetrance = not all carriers show phenotype (e.g. BRCA2: ~70% lifetime breast cancer risk, not 100%).
Expressivity
The degree to which a condition is expressed in those who do show features. Variable expressivity = same mutation causes mild to severe disease (e.g. neurofibromatosis type 1).
De Novo (New) Mutations
Pathogenic variant arising for the first time in an individual, not inherited from either parent. Parental recurrence risk typically <1% for most. Important in severe AD conditions where reproduction is reduced.
Mosaicism
Mutation present in only a subset of cells. Gonadal mosaicism: mutation confined to germ cells; parents appear unaffected but can have multiple affected children. Explains recurrence of AD conditions in families with unaffected parents.
📋 Pedigree Drawing & Analysis
Pedigree Analysis Steps
Identify affected individuals and their relationships
Look for sex predominance (M>F = XLR?)
Check for skipped generations (AR or incomplete penetrance AD?)
Male-to-male transmission? (rules out X-linked)
Consider consanguinity loops in GCC families
Calculate carrier probability in each line
Red Flags in Pedigree
Multiple loops/shared ancestry = consanguinity
Three generations affected (vertical) = AD
Horizontal (sibling) pattern only = AR
Only males affected = suspect XLR
Only maternal transmission = consider mitochondrial
Single affected child, young parents = de novo
🌎 Consanguinity in the GCC
First-cousin marriage rates: 25–60% among GCC nationals (highest globally). First-cousin unions increase the risk of autosomal recessive conditions by approximately 2-fold compared to the general population (coefficient of relationship F=0.0625).
Saudi Arabia
Consanguinity ~45–57%
SCD prevalence: ~0.26% (Eastern Province highest)
SCT: ~4–6%
Beta-thal: ~0.7% of population
Mandatory premarital screening since 2004
UAE / Qatar
Consanguinity ~40–54%
Beta-thal major: ~0.3–1%
CAH: elevated incidence
CAGS (Abu Dhabi): regional genetics leader
UAE national premarital mandatory
Bahrain / Kuwait / Oman
Bahrain SCD SCT ~4%
Kuwait: consanguinity ~30%
Oman: beta-thal + SCD high in coastal regions
All have premarital or prenatal programmes
🔵 Sickle Cell Disease (SCD)
Genetics
AR: mutation in HBB gene (chr 11) — Glu→Val at position 6
Beta-thalassaemia is common across the Mediterranean belt and into the Middle East and Gulf — high prevalence in UAE, Qatar, Oman, and among Arab populations.
Genotype
Phenotype
Transfusion Need
beta+/beta+ or beta0/beta0
Thalassaemia Major (Cooley's Anaemia)
Regular, lifelong
beta+/normal or beta0/normal
Thalassaemia Minor (Trait)
None — mild microcytosis
beta/delta-beta or variable
Thalassaemia Intermedia
Occasional
Key nursing alert: Do NOT give iron to a patient with thalassaemia trait and microcytosis without first checking ferritin. Iron supplementation in iron-replete thalassaemia causes iron overload.
📊 Other Important GCC Genetic Conditions
Congenital Adrenal Hyperplasia (CAH)
AR — CYP21A2 gene; high GCC incidence
Classic: salt-wasting (severe) or simple virilising
Detects micro-deletions/duplications to ~50 kb; preferred if ultrasound anomaly found; variants of uncertain significance (VUS) possible
👶 GCC Neonatal Screening Programmes
GCC countries have expanded newborn blood spot panels significantly. The heel-prick is collected at 48–72 hours of age.
Condition
Marker Screened
Treatment Available
GCC Status
PKU
Phenylalanine
Dietary restriction
All GCC
Congenital Hypothyroidism
TSH (+ T4)
Thyroxine
All GCC
CAH
17-OHP
Steroids
All GCC
Biotinidase Deficiency
Biotinidase activity
Biotin supplements
Most GCC
MCAD Deficiency
Acylcarnitines (C8)
Diet/avoid fasting
Saudi Arabia, UAE
Homocystinuria
Methionine
B6/diet/betaine
Most GCC
Maple Syrup Urine Disease
Leucine/Isoleucine/Valine
Dietary restriction
Most GCC
Galactosaemia
Galactose/GALT enzyme
Galactose-free diet
Most GCC
Sickle Cell/Thalassaemia
Haemoglobin electrophoresis
Management/transfusions
All GCC
G6PD Deficiency
G6PD enzyme activity
Trigger avoidance
All GCC
⚡ G6PD Deficiency
G6PD deficiency is X-linked recessive with 5–25% prevalence in parts of GCC (highest in Oman, Eastern Saudi Arabia, parts of UAE). Males hemizygous are affected; carrier females variable.
Food Fava beans (habas/fool medames) — common GCC food
Drug Methylene blue (used in methaemoglobinaemia)
Other Infections, metabolic acidosis
Fava beans are culturally common in GCC (ful). Counsel all G6PD-deficient patients explicitly about this dietary risk.
Clinical Manifestations
Neonatal jaundice: Significant risk — can lead to kernicterus if untreated
Acute haemolytic anaemia: After oxidative trigger exposure; Heinz bodies on film
Favism: Acute haemolysis after fava bean ingestion
Chronic non-spherocytic haemolytic anaemia (rare, Class I)
Nursing Actions
All newborns in GCC screened for G6PD
Educate family on trigger list at diagnosis
Provide written medication warning card
Advise prescribers to check G6PD status before nitrofurantoin/dapsone/primaquine
📊 Developmental Disability Genetic Workup
First-Line Investigations
Chromosomal Microarray (CMA): First-line for unexplained intellectual disability (ID) / developmental delay (DD) / autism; detects pathogenic CNVs in ~15–20%
Metabolic Screen: Amino acids, organic acids, ammonia, lactate, thyroid function — especially in GCC given high AR metabolic disease prevalence
FRAXA Testing (Fragile X): FMR1 gene CGG expansion; commonest inherited cause of ID in males; also associated with POI (females) and FXTAS (older males)
Karyotype: If morphological features suggest chromosomal condition
Autism Genetic Counselling in GCC
ASD has significant genetic contribution (~80% heritability)
Perform CMA and FRAXA as first-line in every ASD case
Consanguineous families: higher rate of AR gene mutations causing ASD-like phenotype
Whole exome sequencing (WES) if first-line negative
Family cascade screening saves lives in cardiac genetics. When one family member is diagnosed with inherited cardiomyopathy or channelopathy, nurse must facilitate referral of all first-degree relatives.
💊 Pharmacogenomics
Gene
Drug Affected
Clinical Risk
Nursing Action
CYP2D6 Ultra-rapid metaboliser (UM)
Codeine → excess morphine conversion
Respiratory depression, death (especially children)
Avoid codeine in UMs; FDA/EMA black box. Check CYP2D6 status before prescribing
CYP2D6 Poor metaboliser (PM)
Tramadol, metoprolol, antidepressants
Drug toxicity or lack of efficacy
Dose adjustment required
CYP2C19 Poor metaboliser
Clopidogrel (pro-drug)
Inadequate platelet inhibition → stent thrombosis
Consider alternative antiplatelet (prasugrel/ticagrelor)
CYP2C19 UM
PPIs (omeprazole)
Rapid PPI metabolism → reduced H. pylori eradication
Consider dose increase or vonoprazan
TPMT/NUDT15
Thiopurines (azathioprine, 6-MP)
Severe myelosuppression if deficient
Test TPMT/NUDT15 before starting; dose-reduce if variant
GCC populations have distinct pharmacogenomic variant frequencies. CYP2D6 UM alleles (CYP2D6*1xN, *2xN) may be more prevalent in some Arab populations. Pharmacogenomic testing increasingly available at KFSH and CAGS.
🏴 Premarital Screening Programmes in GCC
Country
Programme
Conditions Screened
Nurse Role
Saudi Arabia
Mandatory since 2004
Haemoglobinopathies (SCD, thal), HBV, HCV, HIV
Pre-test counselling, result disclosure, referral to geneticist if both carriers
UAE
Mandatory (nationals)
Haemoglobinopathies + expanded panel
Counselling + documentation
Qatar
Mandatory
Haemoglobinopathies, infectious diseases
Nurse-led counselling in primary care
Bahrain
Mandatory
Haemoglobinopathies, HIV, HBV/HCV
Pre/post-test counselling
Kuwait
Mandatory
Haemoglobinopathies
Result counselling, referral
Oman
Mandatory (since 2009)
Thalassaemia, SCD + infectious diseases
Nurse counselling integral
Important: In all GCC countries, a positive (incompatible) premarital result does NOT legally prevent marriage — it is an informed choice. The nurse's role is non-directive counselling, not gatekeeping.
🌟 Islamic Ethical Framework for Genetic Testing
Majority Scholarly Views
Genetic testing for diagnosis: permissible (halal) — promotes prevention and treatment
Premarital carrier testing: strongly encouraged
Prenatal diagnosis: permissible, especially if serious condition suspected
Termination of pregnancy (TOP): highly controversial; most scholars permit only for lethal conditions before 120 days (ensoulment); varies by country law and scholarly tradition
Country Differences
UAE: Strict embryonic research laws; TOP limited to medical necessity
Saudi Arabia: TOP not generally permitted; compassionate exceptions exist
Bahrain/Kuwait: Similar to Saudi approach
Qatar: Islamic Fiqh Academy guidance: lethal anomaly TOP permissible <120d
Genetic counsellors must present all options without imposing personal views. Document discussions. Involve patient's religious scholar/spiritual advisor if requested.
🏛 GCC Genetics Centres & Infrastructure
KFSH — Riyadh
King Faisal Specialist Hospital & Research Centre: one of the leading genetic departments in the Middle East; comprehensive diagnostic, molecular and metabolic genetics; WES/WGS available; training programme for genetic counsellors.
CAGS — Abu Dhabi
Centre for Arab Genomic Studies: UAE-based; maintains the CTGA (Catalogue for Transmission Genetics in Arabs); >3,800 genetic disorders documented in Arab populations; research and clinical collaboration across GCC.
BGI-Gulf & Private Labs
BGI-Gulf (Dubai): comprehensive sequencing including NIPT, WES, pharmacogenomics; several private labs in Dubai/Riyadh/Doha offer expanded carrier screening and NIPT. Genetic counsellor shortage means nurses often provide first-line counselling.
GCC faces a significant shortage of certified genetic counsellors (CGCs). Nurses who develop expertise in genetics play a critical frontline role. The Arab Board of Health Specializations is developing regional genetics training pathways.
📈 Inheritance Risk Calculator
Select the inheritance pattern and parental status to calculate offspring risk.
Offspring risk for
—
📋 Premarital Screening Counselling Checklist
Select country and partner carrier statuses for a tailored counselling guide.
📝 Practice MCQs — Genetics & Genetic Counselling
Select one answer per question. Instant feedback provided. Score shown at end.